[(5S,6S,7S,8R,9S,11Z,13S,14S,15S,16Z,18S)-8,14,18-trihydroxy-5,7,9,11,13,15-hexamethyl-19-[(2S,3R)-3-methyl-6-oxooxan-2-yl]nonadeca-11,16-dien-6-yl] carbamate

C32H57NO7 — CID 11584966

IUPAC[(5S,6S,7S,8R,9S,11Z,13S,14S,15S,16Z,18S)-8,14,18-trihydroxy-5,7,9,11,13,15-hexamethyl-19-[(2S,3R)-3-methyl-6-oxooxan-2-yl]nonadeca-11,16-dien-6-yl] carbamate
SMILESCCCC[C@H](C)[C@H](OC(N)=O)[C@@H](C)[C@H](O)[C@@H](C)C/C(C)=C\[C@H](C)[C@@H](O)[C@@H](C)/C=C\[C@@H](O)C[C@@H]1OC(=O)CC[C@H]1C
InChIInChI=1S/C32H57NO7/c1-9-10-11-22(5)31(40-32(33)38)25(8)30(37)24(7)17-19(2)16-23(6)29(36)21(4)12-14-26(34)18-27-20(3)13-15-28(35)39-27/h12,14,16,20-27,29-31,34,36-37H,9-11,13,15,17-18H2,1-8H3,(H2,33,38)/b14-12-,19-16-/t20-,21+,22+,23+,24+,25+,26-,27+,29+,30-,31+/m1/s1
InChIKeyHTDAVHMDYSADCF-ZGBRNSSHSA-N
MW567.81 g/mol
LogP5.53
Rot. Bonds17

About [(5S,6S,7S,8R,9S,11Z,13S,14S,15S,16Z,18S)-8,14,18-trihydroxy-5,7,9,11,13,15-hexamethyl-19-[(2S,3R)-3-methyl-6-oxooxan-2-yl]nonadeca-11,16-dien-6-yl] carbamate

[(5S,6S,7S,8R,9S,11Z,13S,14S,15S,16Z,18S)-8,14,18-trihydroxy-5,7,9,11,13,15-hexamethyl-19-[(2S,3R)-3-methyl-6-oxooxan-2-yl]nonadeca-11,16-dien-6-yl] carbamate (PubChem CID 11584966) has the molecular formula C32H57NO7 and a molecular weight of 567.81 g/mol. Its IUPAC name is [(5S,6S,7S,8R,9S,11Z,13S,14S,15S,16Z,18S)-8,14,18-trihydroxy-5,7,9,11,13,15-hexamethyl-19-[(2S,3R)-3-methyl-6-oxooxan-2-yl]nonadeca-11,16-dien-6-yl] carbamate.

Molecular Properties

Compound Name[(5S,6S,7S,8R,9S,11Z,13S,14S,15S,16Z,18S)-8,14,18-trihydroxy-5,7,9,11,13,15-hexamethyl-19-[(2S,3R)-3-methyl-6-oxooxan-2-yl]nonadeca-11,16-dien-6-yl] carbamate
PubChem CID11584966
Molecular FormulaC32H57NO7
Molecular Weight567.81 g/mol
Exact Mass567.41
IUPAC Name[(5S,6S,7S,8R,9S,11Z,13S,14S,15S,16Z,18S)-8,14,18-trihydroxy-5,7,9,11,13,15-hexamethyl-19-[(2S,3R)-3-methyl-6-oxooxan-2-yl]nonadeca-11,16-dien-6-yl] carbamate
SMILESCCCC[C@H](C)[C@H](OC(N)=O)[C@@H](C)[C@H](O)[C@@H](C)C/C(C)=C\[C@H](C)[C@@H](O)[C@@H](C)/C=C\[C@@H](O)C[C@@H]1OC(=O)CC[C@H]1C
InChIInChI=1S/C32H57NO7/c1-9-10-11-22(5)31(40-32(33)38)25(8)30(37)24(7)17-19(2)16-23(6)29(36)21(4)12-14-26(34)18-27-20(3)13-15-28(35)39-27/h12,14,16,20-27,29-31,34,36-37H,9-11,13,15,17-18H2,1-8H3,(H2,33,38)/b14-12-,19-16-/t20-,21+,22+,23+,24+,25+,26-,27+,29+,30-,31+/m1/s1
InChIKeyHTDAVHMDYSADCF-ZGBRNSSHSA-N
XLogP5.53
TPSA139.31 Ų
H-Bond Donors4
H-Bond Acceptors7
Rotatable Bonds17
Heavy Atoms40
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500567.81
LogP ≤ 55.53
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [(5S,6S,7S,8R,9S,11Z,13S,14S,15S,16Z,18S)-8,14,18-trihydroxy-5,7,9,11,13,15-hexamethyl-19-[(2S,3R)-3-methyl-6-oxooxan-2-yl]nonadeca-11,16-dien-6-yl] carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(5S,6S,7S,8R,9S,11Z,13S,14S,15S,16Z,18S)-8,14,18-trihydroxy-5,7,9,11,13,15-hexamethyl-19-[(2S,3R)-3-methyl-6-oxooxan-2-yl]nonadeca-11,16-dien-6-yl] carbamate?
The IUPAC name of [(5S,6S,7S,8R,9S,11Z,13S,14S,15S,16Z,18S)-8,14,18-trihydroxy-5,7,9,11,13,15-hexamethyl-19-[(2S,3R)-3-methyl-6-oxooxan-2-yl]nonadeca-11,16-dien-6-yl] carbamate (CID 11584966) is [(5S,6S,7S,8R,9S,11Z,13S,14S,15S,16Z,18S)-8,14,18-trihydroxy-5,7,9,11,13,15-hexamethyl-19-[(2S,3R)-3-methyl-6-oxooxan-2-yl]nonadeca-11,16-dien-6-yl] carbamate.
What is the SMILES notation for [(5S,6S,7S,8R,9S,11Z,13S,14S,15S,16Z,18S)-8,14,18-trihydroxy-5,7,9,11,13,15-hexamethyl-19-[(2S,3R)-3-methyl-6-oxooxan-2-yl]nonadeca-11,16-dien-6-yl] carbamate?
The canonical SMILES for [(5S,6S,7S,8R,9S,11Z,13S,14S,15S,16Z,18S)-8,14,18-trihydroxy-5,7,9,11,13,15-hexamethyl-19-[(2S,3R)-3-methyl-6-oxooxan-2-yl]nonadeca-11,16-dien-6-yl] carbamate is CCCC[C@H](C)[C@H](OC(N)=O)[C@@H](C)[C@H](O)[C@@H](C)C/C(C)=C\[C@H](C)[C@@H](O)[C@@H](C)/C=C\[C@@H](O)C[C@@H]1OC(=O)CC[C@H]1C.
What is the InChIKey of [(5S,6S,7S,8R,9S,11Z,13S,14S,15S,16Z,18S)-8,14,18-trihydroxy-5,7,9,11,13,15-hexamethyl-19-[(2S,3R)-3-methyl-6-oxooxan-2-yl]nonadeca-11,16-dien-6-yl] carbamate?
The InChIKey is HTDAVHMDYSADCF-ZGBRNSSHSA-N. The full InChI is InChI=1S/C32H57NO7/c1-9-10-11-22(5)31(40-32(33)38)25(8)30(37)24(7)17-19(2)16-23(6)29(36)21(4)12-14-26(34)18-27-20(3)13-15-28(35)39-27/h12,14,16,20-27,29-31,34,36-37H,9-11,13,15,17-18H2,1-8H3,(H2,33,38)/b14-12-,19-16-/t20-,21+,22+,23+,24+,25+,26-,27+,29+,30-,31+/m1/s1.
What are the key properties of [(5S,6S,7S,8R,9S,11Z,13S,14S,15S,16Z,18S)-8,14,18-trihydroxy-5,7,9,11,13,15-hexamethyl-19-[(2S,3R)-3-methyl-6-oxooxan-2-yl]nonadeca-11,16-dien-6-yl] carbamate?
[(5S,6S,7S,8R,9S,11Z,13S,14S,15S,16Z,18S)-8,14,18-trihydroxy-5,7,9,11,13,15-hexamethyl-19-[(2S,3R)-3-methyl-6-oxooxan-2-yl]nonadeca-11,16-dien-6-yl] carbamate has a molecular weight of 567.81 g/mol, XLogP of 5.53, 17 rotatable bonds, 4 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for [(5S,6S,7S,8R,9S,11Z,13S,14S,15S,16Z,18S)-8,14,18-trihydroxy-5,7,9,11,13,15-hexamethyl-19-[(2S,3R)-3-methyl-6-oxooxan-2-yl]nonadeca-11,16-dien-6-yl] carbamate is sourced from PubChem (CID 11584966), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).